SEARCH OUR PAGES

Investors

Investors

Publications & information

Press Releases

Read more +

Corporate Presentation

Read more +

Regulated Information

Read more +

General Shareholders' Meetings

Read more +

Financial Statements

Reference document
Semester Financial report

Read more +

Live stock price

Click here for live stock price

Information

OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris

  • ISIN: FR0012127173
  • Ticker: OSE
  • Type of listing: continuous
  • Number of outstanding shares: 14,967,012 shares as of December 31, 2019
  • Eligible to Long-Only Deferred Settlement Service
  • Edison Jonas Peciulis

    E-MAIL
  • H.C. Wainwright & CO Swayampakula Ramakanth

    E-MAIL
  • LifeSci Capital Jacques Villefranc

    E-MAIL
  • Rx Securities Joseph Hedden

    E-MAIL
  • Bryan, Garnier & Co Olga Smolentseva

    E-MAIL
  • Degroof Petercam Thomas Guillot

    E-MAIL
  • Gilbert Dupont Jamila El Bougrini

  • Gilbert Dupont Guillaume Cuvillier

  • Invest Securities Martial Descoutures

    E-MAIL
  • Kepler Cheuvreux Thomas Landemaine

    E-MAIL
  • Portzamparc Christophe Dombu

    E-MAIL

Analyst Reports

2020

2019

2018

2017

  • LifeSci Capital , June Read+
  • Aurgalys , May Read+
  • LifeSci Capital Initiation Report , February Read+
  • Kepler Cheuvreux Initiation note , February Read+
  • Aurgalys , January Read+

2016

All opinions, estimates or forecasts on the performance of OSE Immunotherapeutics are solely those of the analysts who issue them and do not in any way represent the opinions or forecasts of the Company or its management.